Literature DB >> 10789895

Melanin decreases clastogenic effects of ionizing radiation in human and mouse somatic cells and modifies the radioadaptive response.

I Mosse1, L Kostrova, S Subbot, I Maksimenya, V Molophei.   

Abstract

Melanin's influence on the chromosome aberration frequency induced by radiation in human lymphocytes and mouse bone marrow cells has been studied. We revealed earlier that melanin significantly decreases the frequencies of different radiation-induced mutations in animal germ cells. Melanin protection in somatic cells has been found to be less effective. The melanin effect in somatic cells depends on radiation dose: the lower the damage level, the better the melanin protection. In order to determine the influence of melanin at low radiation doses, the adaptive response was investigated in mouse bone marrow cells in vivo. The level of chromosome aberrations in these cells after fractionated irradiation of 0.2 Gy+1.5 Gy with a 4-h interval was about half that after a single dose of 1.7 Gy. If melanin was injected prior to irradiation, the aberration level decreased by a factor of about two in both cases. This observed result may be due to the potential radioprotective effect of melanin and to the absence of any adaptive response, whereas in the case of melanin application between the priming and challenge doses, the combined effect of the adaptive response as well as melanin protection resulted in a 4-fold decrease of chromosome aberrations. These results allow us to draw the following conclusions: adaptive response can be prevented by a radioprotector such as melanin, and melanin is capable of completely removing low-dose radiation effects.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789895     DOI: 10.1007/pl00007685

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  7 in total

1.  Interspecies diversity of the genome responses to chronic irradiation in natural populations of rodents.

Authors:  E A Gileva; V N Bol'shakov; L E Yalkovskaya
Journal:  Dokl Biol Sci       Date:  2002 Nov-Dec

2.  Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer.

Authors:  Andrew D Schweitzer; Ekaterina Revskaya; Peter Chu; Valeria Pazo; Matthew Friedman; Joshua D Nosanchuk; Sean Cahill; Susana Frases; Arturo Casadevall; Ekaterina Dadachova
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

3.  Gene profiling characteristics of radioadaptive response in AG01522 normal human fibroblasts.

Authors:  Jue Hou; Fan Wang; Peizhong Kong; Peter K N Yu; Hongzhi Wang; Wei Han
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 4.  In vivo radioadaptive response: a review of studies relevant to radiation-induced cancer risk.

Authors:  M Nenoi; B Wang; G Vares
Journal:  Hum Exp Toxicol       Date:  2014-06-12       Impact factor: 2.903

Review 5.  Immunotherapy in the management of melanoma: current status.

Authors:  Dylan Alston; Jerry D Brewer
Journal:  Immunotargets Ther       Date:  2013-02-23

6.  Dose and Radioadaptive Response Analysis of Micronucleus Induction in Mouse Bone Marrow.

Authors:  Laura A Bannister; Rebecca R Mantha; Yvonne Devantier; Eugenia S Petoukhov; Chantal L A Brideau; Mandy L Serran; Dmitry Y Klokov
Journal:  Int J Mol Sci       Date:  2016-09-13       Impact factor: 5.923

7.  Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors.

Authors:  Andrew D Schweitzer; Robertha C Howell; Zewei Jiang; Ruth A Bryan; Gary Gerfen; Chin-Cheng Chen; Dennis Mah; Sean Cahill; Arturo Casadevall; Ekaterina Dadachova
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.